The trientine crisis in Canada: a call to advocacy

Can J Gastroenterol Hepatol. 2014 Apr;28(4):184. doi: 10.1155/2014/672809.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Canada
  • Chelating Agents / economics*
  • Chelating Agents / therapeutic use
  • Consumer Advocacy
  • Hepatolenticular Degeneration / drug therapy*
  • Humans
  • Prescription Fees*
  • Trientine / economics*
  • Trientine / therapeutic use

Substances

  • Chelating Agents
  • Trientine